Skip to content

STUDY OF PRACTICES OF BLOOD / BLOOD PRODUCT TRANSFUSION IN A PEDIATRIC INTENSIVE CARE UNIT

AN OBSERVATIONAL STUDY OF CURRENT PRACTICES OF BLOOD / BLOOD PRODUCT TRANSFUSION IN A TERTIARY CARE PEDIATRIC INTENSIVE CARE UNIT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033701
Enrollment
185
Registered
2021-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R799- Abnormal finding of blood chemistry, unspecified Health Condition 2: D649- Anemia, unspecified Health Condition 3: D649- Anemia, unspecified Health Condition 4: D689- Coagulation defect, unspecified Health Condition 5: D759- Disease of blood and blood-formingorgans, unspecified Health Condition 6: D589- Hereditary hemolytic anemia, unspecified Health Condition 7: D509- Iron deficiency anemia, unspecified Health Condition 8: I52- Other heart disorders in diseasesclassifi

Interventions

None listed

Sponsors

No Sponsor MD Dissertation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted to PICU requiring blood or blood product transfusion (Packed red cells, Platelets & FFP).

Exclusion criteria

Exclusion criteria: 1.Patients in PICU receiving cryoprecipitate / Factor VIII or IX / IVIG/ Other serum products. 2.Patients whose parents/ guardians who refuse to consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
1.Frequency of transfusion of blood or blood components (Packed red cells, Platelet concentrate and FFP) in PICU. 2.Indication and cut offâ??s of various blood parameters (Hemoglobin Hb, platelet counts, Prothrombin time or International Normalized Ratio and Activated Partial Thromboplastin Time) used for transfusions. 3.Beneficial effect of the transfusion. 4.Adverse reactions associated with transfusions.Timepoint: Duration of PICU stay

Secondary

MeasureTime frame
Compliance of transfusion practices in (our) PICU when compared to the Indian Academy of Pediatrics (IAP) guidelinesTimepoint: Duration of PICU stay;Final outcome (survival/ death) in patients receiving blood/ blood product transfusion.Timepoint: Duration of PICU stay

Countries

India

Contacts

Public ContactDarshna J Bhanushali

Seth G.S. Medical College and KEM Hospital

milindtullu@yahoo.com9869469974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026